E-LIB Suche - Ergebnisse für: Knopińska-Posłuszny, Wanda

1

P498: INCIDENCE, RISK FACTORS AND OUTCOMES OF SECOND NEOPLA..:

Sobas, Marta ; Knopinska-Posluszny, Wanda ; Piątkowska-Jakubas, Beata...
HemaSphere. 7 (2023) S3 - p. e835897e , 2023

2

Incidence, risk factors, and outcomes of second neoplasms i..:

Sobas, Marta ; Knopinska-Posluszny, Wanda ; Piątkowska-Jakubas, Beata...
Annals of Hematology. 103 (2023) 2 - p. 451-461 , 2023

Link: https://doi.org/10.1007/..

3

The Real-World Evidence on the Fragility and Its Impact on ..:

Tyczyńska, Agata ; Krzempek, Marcela Krzysława ; Cortez, Alexander Jorge...
Cancers. 15 (2023) 13 - p. 3469 , 2023

Link: https://doi.org/10.3390/..

4

Anti-CD20–atezolizumab–polatuzumab vedotin in relapsed/refr..:

Topp, Max S. ; Eradat, Herbert ; Florschütz, Axel...
Journal of Cancer Research and Clinical Oncology. 149 (2022) 2 - p. 811-817 , 2022

Link: https://doi.org/10.1007/..

5

P017: The role of baseline bulk and dissemination measures ..:

Taszner, Michal ; Romanowicz, Grzegorz ; Knopińska-Posłuszny, Wanda...
HemaSphere. 6 (2022) - p. 8-9 , 2022

Link: https://doi.org/10.1097/..

6

Poster: IBCL-203: Umbralisib, a PI3Kδ/CK1ε Dual Inhibitor D..:

Ghosh, Nilanjan ; Zinzani, Pier Luigi ; Samaniego, Felipe...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S244 , 2021

Link: https://doi.org/10.1016/..

7

Correction to: High efficacy of BGD (bendamustine, gemcitab..:

Swoboda, Ryszard ; Giebel, Sebastian ; Knopińska-Posłuszny, Wanda...
Annals of Hematology. 100 (2021) 7 - p. 1919-1919 , 2021

Link: https://doi.org/10.1007/..

8

IBCL-203: Umbralisib, a PI3Kδ/CK1ε Dual Inhibitor Demonstra..:

Ghosh, Nilanjan ; Zinzani, Pier Luigi ; Samaniego, Felipe...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S404 , 2021

Link: https://doi.org/10.1016/..

9

High efficacy of BGD (bendamustine, gemcitabine, and dexame..:

Swoboda, Ryszard ; Giebel, Sebastian ; Knopińska-Posłuszny, Wanda...
Annals of Hematology. 100 (2021) 7 - p. 1755-1767 , 2021

Link: https://doi.org/10.1007/..

10

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε..:

Davids, Matthew S. ; O'Connor, Owen A. ; Jurczak, Wojciech...
Blood Advances. 5 (2021) 23 - p. 5332-5343 , 2021

Link: https://doi.org/10.1182/..

11

Type 2 diabetes mellitus compromises the survival of diffus..:

Drozd-Sokolowska, Joanna ; Zaucha, Jan Maciej ; Biecek, Przemyslaw...
Scientific Reports. 10 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

12

Efficacy of daratumumab monotherapy in real-world heavily p..:

Salomon-Perzyński, Aleksander ; Walter-Croneck, Adam ; Usnarska-Zubkiewicz, Lidia...
Advances in Medical Sciences. 64 (2019) 2 - p. 349-355 , 2019

Link: https://doi.org/10.1016/..

13

Predictive Model for Infection Risk in Myelodysplastic Synd..:

Mądry, Krzysztof ; Lis, Karol ; Biecek, Przemysław...
Clinical Lymphoma Myeloma and Leukemia. 19 (2019) 5 - p. 264-274.e4 , 2019

Link: https://doi.org/10.1016/..

14

Clinicopathologic retrospective analysis of blastic plasmac..:

Owczarczyk-Saczonek, Agnieszka ; Sokołowska-Wojdyło, Małgorzata ; Olszewska, Berenika...
Advances in Dermatology and Allergology. 35 (2018) 2 - p. 128-138 , 2018

Link: https://doi.org/10.5114/..

15

Efficacy and Safety of Bendamustine and Ibrutinib in Previo..:

Andrasiak, Iga ; Rybka, Justyna ; Knopinska-Posluszny, Wanda.
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 5 - p. 268-273 , 2017

Link: https://doi.org/10.1016/..